Manuel Rogg

712 total citations
22 papers, 350 citations indexed

About

Manuel Rogg is a scholar working on Nephrology, Molecular Biology and Genetics. According to data from OpenAlex, Manuel Rogg has authored 22 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Nephrology, 11 papers in Molecular Biology and 7 papers in Genetics. Recurrent topics in Manuel Rogg's work include Renal Diseases and Glomerulopathies (13 papers), Renal and related cancers (6 papers) and Genetic and Kidney Cyst Diseases (6 papers). Manuel Rogg is often cited by papers focused on Renal Diseases and Glomerulopathies (13 papers), Renal and related cancers (6 papers) and Genetic and Kidney Cyst Diseases (6 papers). Manuel Rogg collaborates with scholars based in Germany, Japan and United States. Manuel Rogg's co-authors include Christoph Schell, Tobias B. Huber, Mako Yasuda‒Yamahara, George Kassiotis, Huipeng Jiao, Oliver Schilling, George R. Young, Masahiro Nagata, Nikos Oikonomou and Vangelis Kondylis and has published in prestigious journals such as Nature, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Manuel Rogg

21 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manuel Rogg Germany 10 211 92 91 55 42 22 350
Rhiannon I. Campden Canada 10 190 0.9× 65 0.7× 28 0.3× 29 0.5× 42 1.0× 14 376
Tom Coffman United States 4 149 0.7× 61 0.7× 33 0.4× 40 0.7× 47 1.1× 6 349
Nadine Artelt Germany 11 141 0.7× 23 0.3× 164 1.8× 50 0.9× 47 1.1× 16 298
Valérie Boitez France 7 173 0.8× 34 0.4× 45 0.5× 101 1.8× 47 1.1× 8 314
Sharad C. Paudyal United States 8 287 1.4× 36 0.4× 68 0.7× 25 0.5× 47 1.1× 9 359
Aleksandr Kirov United States 7 288 1.4× 114 1.2× 17 0.2× 17 0.3× 48 1.1× 8 350
Anna Baruzzi Italy 9 145 0.7× 128 1.4× 37 0.4× 16 0.3× 44 1.0× 10 336
Austin Gay United States 6 288 1.4× 37 0.4× 14 0.2× 37 0.7× 76 1.8× 6 396
Chiu‐Yueh Chen Taiwan 11 125 0.6× 17 0.2× 119 1.3× 62 1.1× 12 0.3× 19 324
Anita A. Wasik Finland 9 194 0.9× 14 0.2× 81 0.9× 47 0.9× 146 3.5× 14 379

Countries citing papers authored by Manuel Rogg

Since Specialization
Citations

This map shows the geographic impact of Manuel Rogg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Rogg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Rogg more than expected).

Fields of papers citing papers by Manuel Rogg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuel Rogg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Rogg. The network helps show where Manuel Rogg may publish in the future.

Co-authorship network of co-authors of Manuel Rogg

This figure shows the co-authorship network connecting the top 25 collaborators of Manuel Rogg. A scholar is included among the top collaborators of Manuel Rogg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuel Rogg. Manuel Rogg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rogg, Manuel, Eva L. Decker, Martin Pöhl, et al.. (2025). Thrombospondin-1 inhibits alternative complement pathway activation in antineutrophil cytoplasmic antibody-associated vasculitis. Journal of Clinical Investigation. 135(13). 2 indexed citations
2.
Wess, Maximilian, Manuel Rogg, Martin Werner, et al.. (2025). Versatile roles of annexin A4 in clear cell renal cell carcinoma: Impact on membrane repair, transcriptional signatures, and composition of the tumor microenvironment. iScience. 28(4). 112198–112198. 1 indexed citations
4.
Osbelt, Lisa, Bei Zhao, Till Robin Lesker, et al.. (2025). Laboratory mice engrafted with natural gut microbiota possess a wildling-like phenotype. Nature Communications. 16(1). 5301–5301. 5 indexed citations
6.
Dabrowska‐Schlepp, Paulina, Andreas Büsch, Andreas Schaaf, et al.. (2025). Effective long-term treatment with moss-produced factor H by overcoming the antibody response in a mouse model of C3G. Frontiers in Immunology. 16. 1535547–1535547. 1 indexed citations
7.
Cosenza‐Contreras, Miguel, Niko Pinter, Manuel Rogg, et al.. (2024). TermineR: Extracting information on endogenous proteolytic processing from shotgun proteomics data. PROTEOMICS. 24(19). e2300491–e2300491. 11 indexed citations
8.
Sagar, Sagar, et al.. (2024). Tissue-resident memory T cells break tolerance to renal autoantigens and orchestrate immune-mediated nephritis. Cellular and Molecular Immunology. 21(9). 1066–1081. 3 indexed citations
9.
Rogg, Manuel, Martin Helmstädter, Oliver Gorka, et al.. (2024). ADP-Ribosylation Factor-Interacting Protein 2 Acts as a Novel Regulator of Mitophagy and Autophagy in Podocytes in Diabetic Nephropathy. Antioxidants. 13(1). 81–81. 7 indexed citations
10.
Rogg, Manuel, Martin Helmstädter, Oliver Kretz, et al.. (2023). A YAP/TAZ–ARHGAP29–RhoA Signaling Axis Regulates Podocyte Protrusions and Integrin Adhesions. Cells. 12(13). 1795–1795. 13 indexed citations
11.
Jiao, Huipeng, Laurens Wachsmuth, Masahiro Nagata, et al.. (2022). ADAR1 averts fatal type I interferon induction by ZBP1. Nature. 607(7920). 776–783. 137 indexed citations
12.
Rogg, Manuel, et al.. (2022). Proteome alterations during clonal isolation of established human pancreatic cancer cell lines. Cellular and Molecular Life Sciences. 79(11). 561–561. 7 indexed citations
13.
Rogg, Manuel, Simon K. B. Spohn, Cordula A. Jilg, et al.. (2022). Ex vivo γH2AX assay for tumor radiosensitivity in primary prostate cancer patients and correlation with clinical parameters. Radiation Oncology. 17(1). 163–163. 5 indexed citations
14.
Rogg, Manuel, Martin Helmstädter, Oliver Schilling, et al.. (2021). EPB41L5 controls podocyte extracellular matrix assembly by adhesome-dependent force transmission. Cell Reports. 34(12). 108883–108883. 19 indexed citations
15.
Rogg, Manuel, Robert Dotzauer, Nadine Artelt, et al.. (2021). SRGAP1 Controls Small Rho GTPases To Regulate Podocyte Foot Process Maintenance. Journal of the American Society of Nephrology. 32(3). 563–579. 21 indexed citations
16.
Yasuda‒Yamahara, Mako, et al.. (2018). AIF1L regulates actomyosin contractility and filopodial extensions in human podocytes. PLoS ONE. 13(7). e0200487–e0200487. 16 indexed citations
17.
Schell, Christoph, Benedikt Sabass, Felix Geist, et al.. (2018). ARP3 Controls the Podocyte Architecture at the Kidney Filtration Barrier. Developmental Cell. 47(6). 741–757.e8. 35 indexed citations
18.
Yasuda‒Yamahara, Mako, et al.. (2018). FERMT2 links cortical actin structures, plasma membrane tension and focal adhesion function to stabilize podocyte morphology. Matrix Biology. 68-69. 263–279. 25 indexed citations
19.
Rogg, Manuel, Mako Yasuda‒Yamahara, Ahmed Abed, et al.. (2017). The WD40-domain containing protein CORO2B is specifically enriched in glomerular podocytes and regulates the ventral actin cytoskeleton. Scientific Reports. 7(1). 15910–15910. 19 indexed citations
20.
Schell, Christoph, Oliver Kretz, Manuel Rogg, et al.. (2015). Podocyte-Specific Deletion of Murine CXADR Does Not Impair Podocyte Development, Function or Stress Response. PLoS ONE. 10(6). e0129424–e0129424. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026